Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
CerFlux
AddedFeb 19, 2024
UpdatedJun 18, 2026
CerFlux

CerFlux

Angel

CerFlux: Personalized medicine tech for efficient, cost-effective cancer treatment.

HQ
Birmingham, AL, US
Founded
2018
Overview
Compare
Fundraising
Employees

CerFlux was founded with the mission to revolutionize cancer treatment through personalized medicine technology. The company aims to improve patient outcomes and quality of life by providing tailored treatments that match the unique composition of each tumor. CerFlux offers innovative solutions that reduce the time, pain, and cost associated with traditional cancer treatments. Their market focus is on patients and healthcare providers seeking more effective and individualized cancer therapies.

Notable affiliated individuals include experts in oncology and personalized medicine, although specific names are not provided. CerFlux has garnered attention for its potential to transform cancer treatment protocols, addressing the inefficiencies and inaccuracies of current methods. The company's key achievements include developing technology that personalizes cancer treatment, thereby reducing ineffective drug use. Overall, CerFlux's impact lies in its promise to make cancer treatment more precise, efficient, and patient-centric.

CerFlux - Similar Companies

Empiri logo

Empiri

empiricancer.com

OncoPrecision logo

OncoPrecision

oncoprecision.bio

Certis Oncology Solutions logo

Certis Oncology Solutions

certisoncology.com

BloodQ logo

BloodQ

bloodq.com

xCures logo

xCures

xcures.com

CerRx logo

CerRx

cerrx.com

Palm Therapeutics logo

Palm Therapeutics

Affigen logo

Affigen

affigen.com

Cvergenx logo

Cvergenx

cvergenx.com

VieCure logo

VieCure

viecure.com

CeleFlux logo

CeleFlux

Artera logo

Artera

artera.ai

PanTher Therapeutics logo

PanTher Therapeutics

panthertx.com

Cure Forward logo

Cure Forward

EtiraRx logo

EtiraRx

etirarx.com

CerFlux - Quick Facts

Who are CerFlux's competitors?

Companies similar to CerFlux include Empiri, OncoPrecision, Certis Oncology Solutions and BloodQ.

When was CerFlux founded?

CerFlux was founded in 2018.

Where is CerFlux's headquarters located?

CerFlux's headquarters is located in Birmingham, AL, US.

When was CerFlux's last funding round?

CerFlux's most recent funding round was for $275k (USD) in August 2023.

How much has CerFlux raised to-date?

As of Aug 3, 2023, CerFlux has raised a total of $375k (USD).

How many employees does CerFlux have?

CerFlux has 8 employees as of Feb 4, 2024.

CerFlux - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Americas
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cancer Treatment
Tags
  • Biotech
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified